Viewing StudyNCT00022880

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00022880
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2001-08-15
Brief Title: Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
Sponsor: Corixa Corporation
Organization: Corixa Corporation
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Chronic Lymphocytic Leukemia
Keywords:
Name View
Iodine I 131 Tositumomab View
Chronic Lymphocytic Leukemia View
Dose-Escalation View
Radioimmunotherapy View
Monoclonal Antibody View
Corixa View
Bexxar View
Anti-B1 Antibody View
Tositumomab View
Iodine -131 Anti-B1 Antibody View